Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inogen (INGN) Capital Expenditures (2016 - 2022)

Inogen has reported Capital Expenditures over the past 10 years, most recently at -$2.3 million for Q4 2022.

  • Quarterly results put Capital Expenditures at -$2.3 million for Q4 2022, down 145.48% from a year ago — trailing twelve months through Dec 2022 was $428000.0 (down 92.19% YoY), and the annual figure for FY2025 was $2.5 million, down 24.91%.
  • Capital Expenditures for Q4 2022 was -$2.3 million at Inogen, down from $2.4 million in the prior quarter.
  • Over the last five years, Capital Expenditures for INGN hit a ceiling of $7.9 million in Q4 2018 and a floor of -$3.3 million in Q4 2020.
  • Median Capital Expenditures over the past 5 years was $599000.0 (2019), compared with a mean of $857550.0.
  • Biggest five-year swings in Capital Expenditures: soared 23282.35% in 2018 and later plummeted 420.93% in 2019.
  • Inogen's Capital Expenditures stood at $7.9 million in 2018, then plummeted by 60.35% to $3.1 million in 2019, then tumbled by 205.5% to -$3.3 million in 2020, then soared by 256.17% to $5.1 million in 2021, then tumbled by 145.48% to -$2.3 million in 2022.
  • The last three reported values for Capital Expenditures were -$2.3 million (Q4 2022), $2.4 million (Q3 2022), and -$1.0 million (Q2 2022) per Business Quant data.